{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T15:04:29Z","timestamp":1772636669275,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2023YFC3402805"],"award-info":[{"award-number":["2023YFC3402805"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Science and Technology Program of the Joint Fund of Scientific Research for the Public Hospitals of Inner Mongolia Academy of Medical Sciences","award":["2023GLLH0122"],"award-info":[{"award-number":["2023GLLH0122"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"DOI":"10.1186\/s12880-025-01799-7","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T11:17:43Z","timestamp":1751368663000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Predict status of axillary lymph node after neoadjuvant chemotherapy with dual-energy CT in breast cancer"],"prefix":"10.1186","volume":"25","author":[{"given":"Zhen","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhao-Qing","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Ze","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Ting","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing-Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-Shi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"issue":"5","key":"1799_CR1","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1634\/theoncologist.2018-0228","volume":"24","author":"R Colomer","year":"2019","unstructured":"Colomer R, Saura C, S\u00e1nchez-Rovira P, Pascual T, Rubio IT, Burgu\u00e9s O, et al. Neoadjuvant management of early breast cancer: A clinical and investigational position statement. Oncologist. 2019;24(5):603\u201311.","journal-title":"Oncologist"},{"issue":"8","key":"1799_CR2","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1200\/JCO.1998.16.8.2672","volume":"16","author":"B Fisher","year":"1998","unstructured":"Fisher B, Bryant J, Wolmark N, Mamounas E, Brown A, Fisher ER, et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncology: Official J Am Soc Clin Oncol. 1998;16(8):2672\u201385.","journal-title":"J Clin Oncology: Official J Am Soc Clin Oncol"},{"issue":"6","key":"1799_CR3","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1001\/jama.2011.90","volume":"305","author":"AE Giuliano","year":"2011","unstructured":"Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and Sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305(6):569\u201375.","journal-title":"JAMA"},{"issue":"5","key":"1799_CR4","doi-asserted-by":"publisher","first-page":"e553","DOI":"10.1097\/SLA.0000000000004572","volume":"276","author":"S Kuemmel","year":"2022","unstructured":"Kuemmel S, Heil J, Rueland A, Seiberling C, Harrach H, Schindowski D, et al. A prospective, multicenter registry study to evaluate the clinical feasibility of targeted axillary dissection (TAD) in Node-positive breast Cancer patients. Ann Surg. 2022;276(5):e553\u201362.","journal-title":"Ann Surg"},{"issue":"4","key":"1799_CR5","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1053\/ejso.2002.1385","volume":"29","author":"MP Schijven","year":"2003","unstructured":"Schijven MP, Vingerhoets AJJM, Rutten HJT, Nieuwenhuijzen GAP, Roumen RMH, van Bussel ME, et al. Comparison of morbidity between axillary lymph node dissection and Sentinel node biopsy. Eur J Surg Oncol. 2003;29(4):341\u201350.","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"1799_CR6","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3322\/caac.21253","volume":"65","author":"SF Shaitelman","year":"2015","unstructured":"Shaitelman SF, Cromwell KD, Rasmussen JC, Stout NL, Armer JM, Lasinski BB, et al. Recent progress in the treatment and prevention of cancer-related lymphedema. CA Cancer J Clin. 2015;65(1):55\u201381.","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"1799_CR7","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1001\/jamasurg.2023.1772","volume":"158","author":"S Kuemmel","year":"2023","unstructured":"Kuemmel S, Heil J, Bruzas S, Breit E, Schindowski D, Harrach H, et al. Safety of targeted axillary dissection after neoadjuvant therapy in patients with Node-Positive breast Cancer. JAMA Surg. 2023;158(8):807\u201315.","journal-title":"JAMA Surg"},{"key":"1799_CR8","doi-asserted-by":"publisher","first-page":"666","DOI":"10.3389\/fonc.2018.00666","volume":"8","author":"C-F Chen","year":"2018","unstructured":"Chen C-F, Zhang Y-L, Cai Z-L, Sun S-M, Lu X-F, Lin H-Y, et al. Predictive value of preoperative Multidetector-Row computed tomography for axillary lymph nodes metastasis in patients with breast Cancer. Front Oncol. 2018;8:666.","journal-title":"Front Oncol"},{"issue":"5","key":"1799_CR9","doi-asserted-by":"publisher","first-page":"W641","DOI":"10.2214\/AJR.10.4889","volume":"196","author":"PAT Baltzer","year":"2011","unstructured":"Baltzer PAT, Dietzel M, Burmeister HP, Zoubi R, Gajda M, Camara O, et al. Application of MR mammography beyond local staging: is there a potential to accurately assess axillary lymph nodes? Evaluation of an extended protocol in an initial prospective study. AJR Am J Roentgenol. 2011;196(5):W641\u20137.","journal-title":"AJR Am J Roentgenol"},{"issue":"6","key":"1799_CR10","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3348\/kjr.2022.0731","volume":"24","author":"H-J Lee","year":"2023","unstructured":"Lee H-J, Nguyen A-T, Song MW, Lee JE, Park SB, Jeong WG, et al. Prediction of residual axillary nodal metastasis following neoadjuvant chemotherapy for breast cancer: radiomics analysis based on chest computed tomography. Korean J Radiol. 2023;24(6):498\u2013511.","journal-title":"Korean J Radiol"},{"issue":"3","key":"1799_CR11","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1148\/radiol.2015142631","volume":"276","author":"CH McCollough","year":"2015","unstructured":"McCollough CH, Leng S, Yu L, Fletcher JG. Dual- and Multi-Energy CT: principles, technical approaches, and clinical applications. Radiology. 2015;276(3):637\u201353.","journal-title":"Radiology"},{"key":"1799_CR12","doi-asserted-by":"publisher","first-page":"109832","DOI":"10.1016\/j.ejrad.2021.109832","volume":"142","author":"B Demirler \u015eim\u015fir","year":"2021","unstructured":"Demirler \u015eim\u015fir B, Krug KB, Burke C, Hellmich M, Maintz D, Coche E. Possibility to discriminate benign from malignant breast lesions detected on dual-layer spectral CT-evaluation. Eur J Radiol. 2021;142:109832.","journal-title":"Eur J Radiol"},{"issue":"5","key":"1799_CR13","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.21037\/qims-20-825","volume":"11","author":"X Wang","year":"2021","unstructured":"Wang X, Liu D, Zeng X, Jiang S, Li L, Yu T, et al. Dual-energy CT quantitative parameters for the differentiation of benign from malignant lesions and the prediction of histopathological and molecular subtypes in breast cancer. Quant Imaging Med Surg. 2021;11(5):1946\u201357.","journal-title":"Quant Imaging Med Surg"},{"issue":"1","key":"1799_CR14","doi-asserted-by":"publisher","first-page":"810","DOI":"10.21037\/qims-21-39","volume":"12","author":"X Lan","year":"2022","unstructured":"Lan X, Wang X, Qi J, Chen H, Zeng X, Shi J, et al. Application of machine learning with multiparametric dual-energy computed tomography of the breast to differentiate between benign and malignant lesions. Quant Imaging Med Surg. 2022;12(1):810\u201322.","journal-title":"Quant Imaging Med Surg"},{"issue":"1","key":"1799_CR15","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40644-020-00370-7","volume":"21","author":"X Wang","year":"2021","unstructured":"Wang X, Liu D, Zeng X, Jiang S, Li L, Yu T, et al. Dual-energy CT quantitative parameters for evaluating immunohistochemical biomarkers of invasive breast cancer. Cancer Imaging. 2021;21(1):4.","journal-title":"Cancer Imaging"},{"key":"1799_CR16","doi-asserted-by":"publisher","first-page":"110544","DOI":"10.1016\/j.ejrad.2022.110544","volume":"156","author":"K Barbara Krug","year":"2022","unstructured":"Barbara Krug K, Sch\u00f6mig-Markiefka B, Campbell GM, P\u00fcsken M, Maintz D, Schlamann M, et al. Correlation of CT-data derived from multiparametric dual-layer CT-maps with immunohistochemical biomarkers in invasive breast carcinomas. Eur J Radiol. 2022;156:110544.","journal-title":"Eur J Radiol"},{"issue":"5","key":"1799_CR17","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1007\/s00330-019-06615-9","volume":"30","author":"JI Moon","year":"2020","unstructured":"Moon JI, Choi BH, Baek HJ, Ryu KH, Park SE, Ha JY, et al. Comprehensive analyses with radiological and biological markers of breast cancer on contrast-enhanced chest CT: a single center experience using dual-layer spectral detector CT. Eur Radiol. 2020;30(5):2782\u201390.","journal-title":"Eur Radiol"},{"issue":"2","key":"1799_CR18","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1148\/radiol.2018180544","volume":"289","author":"X Zhang","year":"2018","unstructured":"Zhang X, Zheng C, Yang Z, Cheng Z, Deng H, Chen M, et al. Axillary Sentinel lymph nodes in breast cancer: quantitative evaluation at Dual-Energy CT. Radiology. 2018;289(2):337\u201346.","journal-title":"Radiology"},{"issue":"1","key":"1799_CR19","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s41747-021-00212-6","volume":"5","author":"TW Buus","year":"2021","unstructured":"Buus TW, Sandahl M, Thorup KS, Rasmussen F, Redsted S, Christiansen P, et al. Breast cancer: comparison of quantitative dual-layer spectral CT and axillary ultrasonography for preoperative diagnosis of metastatic axillary lymph nodes. Eur Radiol Exp. 2021;5(1):16.","journal-title":"Eur Radiol Exp"},{"key":"1799_CR20","doi-asserted-by":"publisher","first-page":"967655","DOI":"10.3389\/fonc.2022.967655","volume":"12","author":"H Li","year":"2022","unstructured":"Li H, Wang H, Chen F, Gao L, Zhou Y, Zhou Z, et al. Detection of axillary lymph node metastasis in breast cancer using dual-layer spectral computed tomography. Front Oncol. 2022;12:967655.","journal-title":"Front Oncol"},{"issue":"7","key":"1799_CR21","first-page":"1863","volume":"109","author":"S-Y Wu","year":"2023","unstructured":"Wu S-Y, Li J-W, Wang Y-J, Jin K-R, Yang B-L, Li J-J, et al. Clinical feasibility and oncological safety of non-radioactive targeted axillary dissection after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: a prospective diagnostic and prognostic study. Int J Surg. 2023;109(7):1863\u201370.","journal-title":"Int J Surg"},{"issue":"7","key":"1799_CR22","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1001\/jamasurg.2017.0562","volume":"152","author":"AB Tadros","year":"2017","unstructured":"Tadros AB, Yang WT, Krishnamurthy S, Rauch GM, Smith BD, Valero V, et al. Identification of patients with documented pathologic complete response in the breast after neoadjuvant chemotherapy for omission of axillary surgery. JAMA Surg. 2017;152(7):665\u201370.","journal-title":"JAMA Surg"},{"issue":"12","key":"1799_CR23","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1001\/jamasurg.2018.2696","volume":"153","author":"AU Barron","year":"2018","unstructured":"Barron AU, Hoskin TL, Day CN, Hwang ES, Kuerer HM, Boughey JC. Association of low nodal positivity rate among patients with ERBB2-Positive or Triple-Negative breast Cancer and breast pathologic complete response to neoadjuvant chemotherapy. JAMA Surg. 2018;153(12):1120\u20136.","journal-title":"JAMA Surg"},{"issue":"9","key":"1799_CR24","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1056\/NEJMoa1910549","volume":"382","author":"P Schmid","year":"2020","unstructured":"Schmid P, Cortes J, Pusztai L, McArthur H, K\u00fcmmel S, Bergh J, et al. Pembrolizumab for early Triple-Negative breast Cancer. N Engl J Med. 2020;382(9):810\u201321.","journal-title":"N Engl J Med"},{"issue":"3","key":"1799_CR25","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1093\/annonc\/mdw610","volume":"28","author":"S Loibl","year":"2017","unstructured":"Loibl S, Jackisch C, Schneeweiss A, Schmatloch S, Aktas B, Denkert C, et al. Dual HER2-blockade with Pertuzumab and trastuzumab in HER2-positive early breast cancer: a subanalysis of data from the randomized phase III geparsepto trial. Ann Oncol. 2017;28(3):497\u2013504.","journal-title":"Ann Oncol"},{"issue":"1","key":"1799_CR26","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S1470-2045(17)30716-7","volume":"19","author":"SA Hurvitz","year":"2018","unstructured":"Hurvitz SA, Martin M, Symmans WF, Jung KH, Huang C-S, Thompson AM, et al. Neoadjuvant trastuzumab, Pertuzumab, and chemotherapy versus trastuzumab emtansine plus Pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial. Lancet Oncol. 2018;19(1):115\u201326.","journal-title":"Lancet Oncol"},{"issue":"12","key":"1799_CR27","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.1002\/cncr.25152","volume":"116","author":"LS Dominici","year":"2010","unstructured":"Dominici LS, Negron Gonzalez VM, Buzdar AU, Lucci A, Mittendorf EA, Le-Petross HT, et al. Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2-positive breast cancer. Cancer. 2010;116(12):2884\u20139.","journal-title":"Cancer"},{"key":"1799_CR28","doi-asserted-by":"publisher","first-page":"845823","DOI":"10.3389\/fonc.2022.845823","volume":"12","author":"Z Li","year":"2022","unstructured":"Li Z, Tong Y, Chen X, Shen K. Accuracy of ultrasonographic changes during neoadjuvant chemotherapy to predict axillary lymph node response in clinical node-positive breast cancer patients. Front Oncol. 2022;12:845823.","journal-title":"Front Oncol"},{"issue":"1","key":"1799_CR29","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1148\/radiol.2019190014","volume":"293","author":"R Kim","year":"2019","unstructured":"Kim R, Chang JM, Lee H-B, Lee SH, Kim S-Y, Kim ES, et al. Predicting axillary response to neoadjuvant chemotherapy: breast MRI and US in patients with Node-Positive breast Cancer. Radiology. 2019;293(1):49\u201357.","journal-title":"Radiology"},{"issue":"2","key":"1799_CR30","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.ultrasmedbio.2017.09.020","volume":"44","author":"X Yu","year":"2018","unstructured":"Yu X, Hao X, Wan J, Wang Y, Yu L, Liu B. Correlation between ultrasound appearance of small breast Cancer and axillary lymph node metastasis. Ultrasound Med Biol. 2018;44(2):342\u20139.","journal-title":"Ultrasound Med Biol"},{"issue":"2","key":"1799_CR31","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1148\/radiol.14131480","volume":"271","author":"D Marin","year":"2014","unstructured":"Marin D, Boll DT, Mileto A, Nelson RC. State of the art: dual-energy CT of the abdomen. Radiology. 2014;271(2):327\u201342.","journal-title":"Radiology"},{"issue":"6","key":"1799_CR32","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1007\/s00330-006-0517-6","volume":"17","author":"TRC Johnson","year":"2007","unstructured":"Johnson TRC, Krauss B, Sedlmair M, Grasruck M, Bruder H, Morhard D, et al. Material differentiation by dual energy CT: initial experience. Eur Radiol. 2007;17(6):1510\u20137.","journal-title":"Eur Radiol"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-01799-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-025-01799-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-01799-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T11:17:44Z","timestamp":1751368664000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedimaging.biomedcentral.com\/articles\/10.1186\/s12880-025-01799-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1799"],"URL":"https:\/\/doi.org\/10.1186\/s12880-025-01799-7","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"25 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Peking University Cancer Hospital (No.2018KT33). Informed consent was obtained from all individual participants in the prospective training cohort in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors affirm that human research participants provided informed consent for publication of the images in Figs.\u00a0,  and .","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"233"}}